These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 7864709)

  • 1. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
    Houck P; Hemphill M; LaCroix S; Hirsh D; Cox N
    Arch Intern Med; 1995 Mar; 155(5):533-7. PubMed ID: 7864709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine-resistant influenza A in a nursing facility.
    Degelau J; Somani SK; Cooper SL; Guay DR; Crossley KB
    Arch Intern Med; 1992 Feb; 152(2):390-2. PubMed ID: 1739371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of influenza A outbreaks in nursing homes: amantadine as an adjunct to vaccine--Washington, 1989-90.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Dec; 40(49):841-4. PubMed ID: 1961174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
    Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
    J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antiviral agents to control outbreaks of influenza A infection.
    Monto AS
    Geriatrics; 1994 Dec; 49(12):30-4. PubMed ID: 7982583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home.
    Arden NH; Patriarca PA; Fasano MB; Lui KJ; Harmon MW; Kendal AP; Rimland D
    Arch Intern Med; 1988 Apr; 148(4):865-8. PubMed ID: 3355306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of rimantadine resistance in field isolates of influenza A viruses.
    Ziegler T; Hemphill ML; Ziegler ML; Perez-Oronoz G; Klimov AI; Hampson AW; Regnery HL; Cox NJ
    J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.
    Iwahashi J; Tsuji K; Ishibashi T; Kajiwara J; Imamura Y; Mori R; Hara K; Kashiwagi T; Ohtsu Y; Hamada N; Maeda H; Toyoda M; Toyoda T
    J Clin Microbiol; 2001 Apr; 39(4):1652-3. PubMed ID: 11283109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).
    Mast EE; Harmon MW; Gravenstein S; Wu SP; Arden NH; Circo R; Tyszka G; Kendal AP; Davis JP
    Am J Epidemiol; 1991 Nov; 134(9):988-97. PubMed ID: 1951297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine and rimantadine for the prevention of influenza A.
    Betts RF
    Semin Respir Infect; 1989 Dec; 4(4):304-10. PubMed ID: 2697053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.
    Hayden FG; Belshe RB; Clover RD; Hay AJ; Oakes MG; Soo W
    N Engl J Med; 1989 Dec; 321(25):1696-702. PubMed ID: 2687687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing influenza: amantadine, rimantadine and beyond.
    Fleming DM
    Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
    Tominack RL; Hayden FG
    Infect Dis Clin North Am; 1987 Jun; 1(2):459-78. PubMed ID: 3332798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases.
    Drinka PJ; Haupt T
    J Am Geriatr Soc; 2007 Jun; 55(6):923-6. PubMed ID: 17537095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
    Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
    J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(1):51-6. PubMed ID: 3872736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreaks of influenza A and B in a highly immunized nursing home population.
    Drinka PJ; Gravenstein S; Krause P; Schilling M; Miller BA; Shult P
    J Fam Pract; 1997 Dec; 45(6):509-14. PubMed ID: 9420587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    Dolin R; Reichman RC; Madore HP; Maynard R; Linton PN; Webber-Jones J
    N Engl J Med; 1982 Sep; 307(10):580-4. PubMed ID: 7050702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
    Englund JA; Champlin RE; Wyde PR; Kantarjian H; Atmar RL; Tarrand J; Yousuf H; Regnery H; Klimov AI; Cox NJ; Whimbey E
    Clin Infect Dis; 1998 Jun; 26(6):1418-24. PubMed ID: 9636873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.